These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1737532)

  • 21. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glutamate decarboxylase (GAD)--an autoantigen in insulin-dependent diabetes mellitus (IDDM)].
    Tursky T; Bandzuchova E
    Bratisl Lek Listy; 1999 Feb; 100(2):85-8. PubMed ID: 10493003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ; Honeyman MC; Harrison LC
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
    Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
    J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
    Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR
    Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface.
    Aguilar-Diosdado M; Parkinson D; Corbett JA; Kwon G; Marshall CA; Gingerich RL; Santiago JV; McDaniel ML
    Diabetes; 1994 Mar; 43(3):418-25. PubMed ID: 8314014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
    Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
    Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.
    Feeney SJ; Myers MA; Mackay IR; Zimmet PZ; Howard N; Verge CF; Rowley MJ
    Diabetes Care; 1997 Sep; 20(9):1403-7. PubMed ID: 9283787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
    Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
    Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 32. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic engineering approaches to the study of insulin-dependent diabetes mellitus markers].
    Pankov IuA
    Vopr Med Khim; 1997; 43(5):349-55. PubMed ID: 9446325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.
    Aanstoot HJ; Kang SM; Kim J; Lindsay LA; Roll U; Knip M; Atkinson M; Mose-Larsen P; Fey S; Ludvigsson J; Landin L; Bruining J; Maclaren N; Akerblom HK; Baekkeskov S
    J Clin Invest; 1996 Jun; 97(12):2772-83. PubMed ID: 8675688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
    Bonifacio E; Bingley PJ
    Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
    [No Abstract]   [Full Text] [Related]  

  • 36. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular autoantigens of type 1 diabetes.
    Solimena M
    Diabetes Metab Rev; 1998 Sep; 14(3):227-40. PubMed ID: 9816471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concordance between twins for beta-cell autoimmunity.
    Leslie RD; Pyke DA
    Diabetes; 1996 Sep; 45(9):1284. PubMed ID: 8772736
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of distinct islet protein autoantigens associated with type 1 diabetes.
    Christie MR
    Autoimmunity; 1993; 15 Suppl():1-3. PubMed ID: 8218841
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy.
    Muhr D; Mollenhauer U; Ziegler AG; Haslbeck M; Standl E; Schnell O
    Diabetes Care; 1997 Jun; 20(6):1009-12. PubMed ID: 9167116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.